Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 766-777
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.766
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.766
Characteristics | SRCS without liver cirrhosis | SRCS with liver cirrhosis | P value |
N = 758810 (%) | N = 11920 (%) | ||
Patient age, mean (SD) | 66.7 (66.6-66.8) | 62.7 (62.2-63.2) | < 0.05 |
Sex | < 0.05 | ||
Female | 293963 (39) | 11920 (34) | |
Male | 464847 (61) | 7901(66) | |
Race N (%) | < 0.05 | ||
White | 546570 (72) | 7996 (67) | |
Black | 96975.918 (13) | 1676 (14) | |
Hispanic | 66092 (9) | 1525 (13) | |
Asian or Pacific Islander | 21930 (3) | 273 (2) | |
Native American | 4325 (1) | 118 (1) | |
Other | 22840 (3) | 330 (3) | |
Insurance, N (%) | < 0.05 | ||
Medicare | 456880 (60) | 6728 (56) | |
Medicaid | 79068 (10) | 2495 (21) | |
Private | 188716 (25) | 2145 (18) | |
Uninsured | 34146 (5) | 552 (5) | |
Household median income, N (%) | < 0.05 | ||
1-38999 | 232348 (31) | 4271 (36) | |
39000-47999 | 210114 (28) | 3055 (26) | |
48000-62900 | 175513 (23) | 2595 (22) | |
> 63000 | 140835 (18) | 1998 (17) | |
Bed size, N (%) | < 0.05 | ||
Small | 124065 (16) | 1665 (14) | |
Medium | 230602 (30) | 3454 (29) | |
Large | 404218 (53) | 6800 (57) | |
Hospital region | < 0.05 | ||
Northeast | 134309 (18) | 1860 (16) | |
Midwest | 170201 (22) | 2360 (20) | |
South | 306180 (40) | 4915 (41) | |
West | 148196 (20) | 2785 (23) | |
Hospital location | < 0.05 | ||
Rural | 51220 (7) | 465 (4) | |
Urban | 707590 (93) | 11455 (96) | |
Charlson comorbidity index, mean (SD) | < 0.05 | ||
0 | 10016 (1) | 0 | |
1 | 166938 (22) | 335 (3) | |
2 | 176043 (23) | 830 (7) | |
3 | 405736 (53) | 10755 (90) |
Markers of decompensated cirrhosis | N (%) | Adjusted odds | Lower limit | Upper limit | P value |
Hypoalbuminemia | 460 (4) | 1.38 | 1.04 | 1.82 | < 0.05 |
Hepatic encephalopathy | 1855 (16) | 3.06 | 2.41 | 3.9 | < 0.05 |
Portal vein thrombosis | 310 (3) | 1.13 | 0.72 | 1.77 | 0.6 |
Variceal upper GI bleed | 825 (7) | 1.81 | 1.03 | 3.19 | < 0.05 |
Ascites | 2155 (18) | 1.91 | 1.62 | 2.27 | < 0.05 |
Coagulopathy | 1290 (11) | 2.18 | 1.86 | 2.56 | < 0.05 |
SBP | 295 (2) | 2.38 | 0.69 | 8.32 | 0.17 |
Hepatorenal syndrome | 945 (8) | 1.69 | 1.22 | 2.34 | < 0.05 |
In-hospital outcomes | Adjusted odds of mortality propensity matched- needs update | Lower limit | Upper limit | P value |
Sepsis | 2.12 | 1.66 | 2.72 | < 0.05 |
AKI on CKD | 0.65 | 0.4 | 1.06 | 0.08 |
AKI | 2.72 | 2.01 | 3.68 | < 0.05 |
AKI on CKD | 2.24 | 1.84 | 2.74 | < 0.05 |
Cardiac arrest | 4.87 | 3.85 | 6.67 | < 0.05 |
Stroke | 1.06 | 0.45 | 2.5 | 0.89 |
Any bleed/hemorrhage | 2.44 | 1.45 | 4.1 | < 0.05 |
Electrolyte and fluid disturbance | 0.95 | 0.45 | 1.99 | 0.89 |
All GI bleed | 0.42 | 0.25 | 0.73 | < 0.05 |
Respiratory failure requiring mechanical ventilation | 1.14 | 0.74 | 1.78 | 0.55 |
- Citation: Dar SH, Rahim M, Hosseini DK, Sarfraz K. Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis. World J Hepatol 2022; 14(4): 766-777
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/766.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.766